GlassScriptPhysician profile
Mary M Abraham
NPI 1003963554
$1,524.28
in general payments reported to CMS, 2019-2025
23 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2021: $18.43 · 2022: $40.17 · 2023: $355 · 2024: $479 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,165 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.23 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $233.82 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $184.80 | 2019-2025 | Lo Loestrin Fe, Orilissa, Ubrelvy |
| Millicent US INC | $179.60 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Sumitomo Pharma America, INC. | $112.28 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $111.43 | 2019 | |
| Shield Therapeutics INC | $86.64 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.60 | 2022-2025 | |
| Coopersurgical, INC. | $63.45 | 2019-2024 | Paragard T 380a |
| Pfizer INC. | $60.54 | 2023-2024 | |
| Exact Sciences Corporation | $52.12 | 2025 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $49.67 | 2025 | Zurzuvae |
| Organon LLC | $47.50 | 2024-2025 | Nexplanon |
| Aspira Women'S Health INC | $43.66 | 2024 | Ova1 |
| Lupin INC. | $38.00 | 2019 | |
| Hologic Sales and Service, LLC | $26.45 | 2023 | Coolseal Generator |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $24.00 | 2023 | Gardasil 9 |
| Mayne Pharma Commercial LLC | $23.91 | 2025 | |
| Amag Pharmaceuticals, INC. | $21.57 | 2019 | |
| Evofem Biosciences, INC. | $18.43 | 2021 | |
| Exeltis, USA INC. | $18.24 | 2025 | Slynd |
| Supernus Pharmaceuticals, INC. | $17.49 | 2025 | Qelbree |
| Avion Pharmaceuticals | $13.19 | 2019 | |
| Allergan, INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.